{"id":193977,"name":"INTUITIVE SURGICAL, INC.","slug":"intuitive-surgical-inc","state":"CA","country":"United States of America","description":"","totalSpending":3190000,"filings":33,"yearlySpending":[{"year":2018,"income":160000},{"year":2019,"income":250000},{"year":2020,"income":240000},{"year":2021,"income":450000},{"year":2022,"income":460000},{"year":2023,"income":570000},{"year":2024,"income":330000},{"year":2025,"income":730000}],"issues":[{"code":"MMM","display":"Medicare/Medicaid"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"SCI","display":"Science/Technology"},{"code":"HCR","display":"Health Issues"},{"code":"TRD","display":"Trade (domestic/foreign)"},{"code":"TAR","display":"Tariff (miscellaneous tariff bills)"}],"firms":["INTUITIVE SURGICAL, INC."],"lobbyists":["DAN JONES","MEGHAN SCOTT","WILLIAM CAMBARDELLA","DAVID BOMAN"],"govEntities":["Food & Drug Administration (FDA)","HOUSE OF REPRESENTATIVES","SENATE","Commerce, Dept of (DOC)","Intl Trade Administration (ITA)","U.S. Trade Representative (USTR)","Treasury, Dept of"],"sampleDescriptions":["healthcare reimbursement policies","comparative effectiveness research in healthcare","medical research issues; science, technology, and R&D policy issues","healthcare regulatory issues, with a focus on issues specific to the medical device industry","healthcare regulatory issues, with a focus on issues specific to the medical device industry"]}